DV
Dividend Vision

RCKT — Rocket Pharmaceuticals Inc

Rocket Pharmaceuticals Inc (RCKT)

Total return is -85.5% over the past 11.5 years, 432.8 points behind SPY at 347.3%. Its deepest 1-year drawdown was 50.9%.

Rocket Pharmaceuticals Inc is an equity stock focused on the biopharmaceutical sector, specifically gene therapy and rare genetic diseases. As an individual stock rather than a diversified fund, it does not currently pay distributions and therefore has no yield profile or regular distribution frequency. This holding appeals primarily to growth-oriented investors seeking exposure to emerging biotechnology innovation rather than income-focused dividend investors.

RCKT key facts

Asset type
Stock
Asset class
Equity
Inception date
02/18/2015
Last close
$3.47
Market cap
$374,533,888
Average volume
1159100.0
Payment date
01/05/2018
Beta
0.445
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.86